How The Pieces Add Up: ESGV Headed For $119
ETF Analyst Target Prices: The Vanguard ESG U.S. Stock ETF (ESGV) has an implied analyst target price of $118.83, indicating a potential upside of 11.26% from its current trading price of $106.81. Key holdings with notable upside include Sandy Spring Bancorp Inc, Pacira BioSciences Inc, and IMAX Corp.
Investor Research Considerations: Analysts' target prices may reflect optimism but could also lead to downgrades if they are based on outdated information. Investors are encouraged to conduct further research to assess the validity of these targets in light of recent developments.
Trade with 70% Backtested Accuracy
Analyst Views on ESGV
About the author
Explore the Details: ESGV Offers a 12% Potential Gain
Vanguard ESG U.S. Stock ETF Analysis: The Vanguard ESG U.S. Stock ETF (ESGV) has an implied analyst target price of $135.54, indicating a potential upside of 12.06% from its recent trading price of $120.95.
Notable Holdings with Upside Potential: Key underlying holdings of ESGV, such as Steven Madden Ltd. (SHOO), Newmark Group Inc (NMRK), and CTS Corp (CTS), show significant upside potential based on analyst target prices, ranging from 13.80% to 14.47%.
Analyst Target Price Justification: The article raises questions about whether analysts' target prices are justified or overly optimistic, suggesting that high targets could lead to downgrades if they do not align with current market conditions.
Investor Research Recommendation: Investors are encouraged to conduct further research to assess the validity of analyst targets in light of recent company and industry developments.
Projected Target Price for ESGV Analyst: $131
Vanguard ESG U.S. Stock ETF Analysis: The Vanguard ESG U.S. Stock ETF (ESGV) has an implied analyst target price of $131.07, indicating a potential upside of 9.74% from its recent trading price of $119.44.
Notable Holdings with Upside Potential: Key underlying holdings of ESGV, such as MakeMyTrip Ltd. (MMYT), Republic Bancorp, Inc. (RBCAA), and Grab Holdings Ltd. (GRAB), show significant upside potential based on analyst target prices, with MMYT having a 33.40% upside.
Market Sentiment and Analyst Justification: The article raises questions about whether analysts' target prices are justified or overly optimistic, suggesting that high targets could lead to future downgrades if they do not align with market realities.
Investor Research Recommendation: Investors are encouraged to conduct further research to assess the validity of analyst targets in light of recent company and industry developments.
Analysts Predict 10% Growth Potential for ESGV Holdings
ETF Analyst Target Price: The Vanguard ESG U.S. Stock ETF (ESGV) has an implied analyst target price of $126.77, indicating a potential upside of 9.51% from its current trading price of $115.76.
Notable Holdings with Upside: Key underlying holdings of ESGV, such as Nomad Foods Ltd (NOMD), Phreesia Inc (PHR), and Ardagh Metal Packaging SA (AMBP), show significant upside potential, with target prices suggesting increases of 44.53%, 25.48%, and 24.05% respectively from their recent trading prices.
Putting the Pieces Together: ESGV May Be Valued at $124
ETF Analyst Target Price: The Vanguard ESG U.S. Stock ETF (ESGV) has an implied analyst target price of $124.48 per unit, indicating a potential upside of 9.64% from its current trading price of $113.53.
Notable Holdings with Upside: Key underlying holdings of ESGV that show significant upside include Teladoc Health Inc (TDOC), PagSeguro Digital Ltd (PAGS), and Hims & Hers Health Inc (HIMS), with expected increases of 24.66%, 22.59%, and 17.55% respectively.
Market Sentiment on Targets: The article raises questions about whether analysts' target prices are justified or overly optimistic, suggesting the need for further investor research into recent company and industry developments.
Caution on Price Targets: A high target price relative to a stock's current trading price may indicate optimism but could also lead to downgrades if the targets do not align with market realities.
Guns, Booze, And Gambling Stocks Are Crushing ESG In Trump's America
Performance of Sin Stocks vs. ESG: In the first six months of President Trump's second term, "sin stocks" related to alcohol, tobacco, and gambling have significantly outperformed ESG-focused investments, with the USA Mutuals Vice Fund rising 16.4% compared to just 3.5% for the Vanguard ESG U.S. Stock ETF.
Investor Trends and Market Dynamics: The shift towards sin stocks reflects a broader investor trend favoring industries benefiting from deregulation and geopolitical tensions, while traditional ESG stocks struggle despite including strong tech companies in their portfolios.
The Implied Analyst 12-Month Target For ESGV
ETF Analyst Target Prices: The Vanguard ESG U.S. Stock ETF (ESGV) has an implied analyst target price of $117.82, indicating an 11.54% upside from its current trading price of $105.63. Key holdings with significant upside include InMode Ltd, LegalZoom.com Inc, and Axcelis Technologies Inc.
Investor Considerations: Analysts' optimistic target prices may reflect future potential but could also lead to downgrades if they are based on outdated information. Investors are encouraged to conduct further research to assess the validity of these targets.
Explore the Details: ESGV Offers a 12% Potential Gain
Vanguard ESG U.S. Stock ETF Analysis: The Vanguard ESG U.S. Stock ETF (ESGV) has an implied analyst target price of $135.54, indicating a potential upside of 12.06% from its recent trading price of $120.95.
Notable Holdings with Upside Potential: Key underlying holdings of ESGV, such as Steven Madden Ltd. (SHOO), Newmark Group Inc (NMRK), and CTS Corp (CTS), show significant upside potential based on analyst target prices, ranging from 13.80% to 14.47%.
Analyst Target Price Justification: The article raises questions about whether analysts' target prices are justified or overly optimistic, suggesting that high targets could lead to downgrades if they do not align with current market conditions.
Investor Research Recommendation: Investors are encouraged to conduct further research to assess the validity of analyst targets in light of recent company and industry developments.
Projected Target Price for ESGV Analyst: $131
Vanguard ESG U.S. Stock ETF Analysis: The Vanguard ESG U.S. Stock ETF (ESGV) has an implied analyst target price of $131.07, indicating a potential upside of 9.74% from its recent trading price of $119.44.
Notable Holdings with Upside Potential: Key underlying holdings of ESGV, such as MakeMyTrip Ltd. (MMYT), Republic Bancorp, Inc. (RBCAA), and Grab Holdings Ltd. (GRAB), show significant upside potential based on analyst target prices, with MMYT having a 33.40% upside.
Market Sentiment and Analyst Justification: The article raises questions about whether analysts' target prices are justified or overly optimistic, suggesting that high targets could lead to future downgrades if they do not align with market realities.
Investor Research Recommendation: Investors are encouraged to conduct further research to assess the validity of analyst targets in light of recent company and industry developments.
Analysts Predict 10% Growth Potential for ESGV Holdings
ETF Analyst Target Price: The Vanguard ESG U.S. Stock ETF (ESGV) has an implied analyst target price of $126.77, indicating a potential upside of 9.51% from its current trading price of $115.76.
Notable Holdings with Upside: Key underlying holdings of ESGV, such as Nomad Foods Ltd (NOMD), Phreesia Inc (PHR), and Ardagh Metal Packaging SA (AMBP), show significant upside potential, with target prices suggesting increases of 44.53%, 25.48%, and 24.05% respectively from their recent trading prices.
Putting the Pieces Together: ESGV May Be Valued at $124
ETF Analyst Target Price: The Vanguard ESG U.S. Stock ETF (ESGV) has an implied analyst target price of $124.48 per unit, indicating a potential upside of 9.64% from its current trading price of $113.53.
Notable Holdings with Upside: Key underlying holdings of ESGV that show significant upside include Teladoc Health Inc (TDOC), PagSeguro Digital Ltd (PAGS), and Hims & Hers Health Inc (HIMS), with expected increases of 24.66%, 22.59%, and 17.55% respectively.
Market Sentiment on Targets: The article raises questions about whether analysts' target prices are justified or overly optimistic, suggesting the need for further investor research into recent company and industry developments.
Caution on Price Targets: A high target price relative to a stock's current trading price may indicate optimism but could also lead to downgrades if the targets do not align with market realities.
Guns, Booze, And Gambling Stocks Are Crushing ESG In Trump's America
Performance of Sin Stocks vs. ESG: In the first six months of President Trump's second term, "sin stocks" related to alcohol, tobacco, and gambling have significantly outperformed ESG-focused investments, with the USA Mutuals Vice Fund rising 16.4% compared to just 3.5% for the Vanguard ESG U.S. Stock ETF.
Investor Trends and Market Dynamics: The shift towards sin stocks reflects a broader investor trend favoring industries benefiting from deregulation and geopolitical tensions, while traditional ESG stocks struggle despite including strong tech companies in their portfolios.
The Implied Analyst 12-Month Target For ESGV
ETF Analyst Target Prices: The Vanguard ESG U.S. Stock ETF (ESGV) has an implied analyst target price of $117.82, indicating an 11.54% upside from its current trading price of $105.63. Key holdings with significant upside include InMode Ltd, LegalZoom.com Inc, and Axcelis Technologies Inc.
Investor Considerations: Analysts' optimistic target prices may reflect future potential but could also lead to downgrades if they are based on outdated information. Investors are encouraged to conduct further research to assess the validity of these targets.
